Last reviewed · How we verify
Non-steroidal anti-inflammatory drug
Non-steroidal anti-inflammatory drug is a Small molecule drug developed by Sucampo Pharma Americas, LLC. It is currently in Phase 2 development. Also known as: Standard Care.
At a glance
| Generic name | Non-steroidal anti-inflammatory drug |
|---|---|
| Also known as | Standard Care |
| Sponsor | Sucampo Pharma Americas, LLC |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Efficacy of Chemically Distinct Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Pain Phenotypes in Adhesive Capsulitis (NA)
- Study of Nonsteroidal Anti-inflammatory Drugs in People With Painful Knee Osteoarthritis (PHASE4)
- Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older
- Ear Pressure Points Plus Pain Meds for Faster Kidney Stone Pain Relief (NA)
- Does the Development of the Repeated Bout Effect Depend on Oxidative Stress and Inflammation? (NA)
- Metformin Safety and Efficacy in Osteoarthritis. (PHASE3)
- FRONT Block for Quality of Recovery After Total Hip Arthroplasty (NA)
- Association of Erectile Dysfunction With Neuropathic Pain, Disease Activity, and Functional Status in Male Patients With Axial Spondyloarthritis: A Cross-Sectional Observational Study
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Non-steroidal anti-inflammatory drug CI brief — competitive landscape report
- Non-steroidal anti-inflammatory drug updates RSS · CI watch RSS
- Sucampo Pharma Americas, LLC portfolio CI
Frequently asked questions about Non-steroidal anti-inflammatory drug
What is Non-steroidal anti-inflammatory drug?
Non-steroidal anti-inflammatory drug is a Small molecule drug developed by Sucampo Pharma Americas, LLC.
Who makes Non-steroidal anti-inflammatory drug?
Non-steroidal anti-inflammatory drug is developed by Sucampo Pharma Americas, LLC (see full Sucampo Pharma Americas, LLC pipeline at /company/sucampo-pharma-americas-llc).
Is Non-steroidal anti-inflammatory drug also known as anything else?
Non-steroidal anti-inflammatory drug is also known as Standard Care.
What development phase is Non-steroidal anti-inflammatory drug in?
Non-steroidal anti-inflammatory drug is in Phase 2.
Related
- Manufacturer: Sucampo Pharma Americas, LLC — full pipeline
- Also known as: Standard Care
- Compare: Non-steroidal anti-inflammatory drug vs similar drugs
- Pricing: Non-steroidal anti-inflammatory drug cost, discount & access